Pentamidine
Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Pentamidine and local guidelines before prescribing.
Antiprotozoal
Mechanism
Antiprotozoal binding DNA.
Uses
Pneumocystis pneumonia (second line), leishmaniasis, trypanosomiasis.
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Hypotension, hypoglycaemia, pancreatitis, nephrotoxicity, QT prolongation.
Interactions
QT-prolonging drugs.
Contraindications and cautions
QT prolongation
Monitoring
Glucose, U&E, ECG
Pregnancy and breastfeeding
Use if essential
Renal and hepatic impairment
Reduce dose in renal impairment
Overdose and reversal
Supportive
Special advice
Monitor glucose and renal function; nebulised for prophylaxis.
More from the textbook: uses, cautions and other points
- Alternatives for co-trimoxazole allergy: clindamycin with primaquine (check G6PD), atovaquone, IV pentamidine.
Respiratory: Infections - Drugs - alcohol, quinine, pentamidine, quinolones, beta-blockers, salicylates, accidental insulin or sulfonylurea.
Endocrinology: NETS and Hypoglycaemia - Drugs: Quinine, pentamidine, quinolones, high-dose salicylates, beta-blockers (which also mask warning symptoms), ACE inhibitors (rarely).
Endocrinology: NETS and Hypoglycaemia - Alternatives - atovaquone, dapsone (check G6PD), nebulised pentamidine.
Clinical Immunology: Secondary immunodeficiency, the immunocompromised host and vaccination
Where it is discussed in the book
- Respiratory: Infections (1 mention)
- Endocrinology: NETS and Hypoglycaemia (2 mentions)
- Clinical Immunology: Secondary immunodeficiency, the immunocompromised host and vaccination (1 mention)
- Integrated respiratory chapter (1 mention)